Arthur He

Q: What is Arthur He's success rate?

Arthur He currently has a success rate of 50.20517292603316.

Q: What is the average return of Arthur He's calls?

Their stock ratings have generated an average return of 18.782751119348326.

HC Wainwright & Co. | Healthcare

Arthur He is an analyst from HC Wainwright & Co. specializing in the Healthcare sector. Ranked #2483 out of 4771 analysts, they have issued 17 stock ratings with a success rate of 50.21% and an average return of 18.78%.

With 17 ratings to date, Arthur He is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 50.21% and an average return of 18.78%, highlighting promising potential as their track record develops further.

#2483

Out of 4771

Total Ratings

+50.21%

Success Rate

+18.78%

Average Return

Recent Ratings Analysis

IMA

Buy

Aug 21, 2026

Target

$28.00

Current

$5.00

Performance

-9.17%

Arthur He rated IMA as Buy on Aug 21, 2026, setting a price target of 28. The stock has underperformed, dropping 9.17% despite the bullish target of 28.

MSLE

Buy

Jul 09, 2026

Target

$18.00

Current

$10.05

Performance

6.46%

On Jul 09, 2026, MSLE was given a Buy rating by Arthur He, with a target price of 18. The stock rallied 6.46% after the rating, narrowing the gap to the target of 18 and validating the bullish stance.

VERA

Buy

Jul 08, 2026

Target

$125.00

Current

$33.60

Performance

-20.81%

VERA received a Buy rating from Arthur He on Jul 08, 2026, aiming for 125. The rating hasn’t played out as hoped, with the stock trading 20.81% below expectations.

PRME

Buy

Jun 29, 2026

Target

$8.00

Current

$3.35

Performance

-9.95%

On Jun 29, 2026, Arthur He published a Buy outlook on PRME, with a target of 8. Market action contradicted the Buy thesis, as shares slipped to 3.35.

SLDB

Buy

Jun 03, 2026

Target

$25.00

Current

$9.07

Performance

32.41%

Arthur He on Jun 03, 2026 assigned SLDB a Buy rating, with a price target of 25. The Buy call aligned well with market performance, producing a gain of 32.41%.

JBIO

Buy

Jun 01, 2026

Target

$55.00

Current

$19.14

Performance

2.96%

On Jun 01, 2026, Arthur He reaffirmed JBIO with a Buy rating, targeting 55. Market indecision has kept the 55 target in a holding pattern.

NKTR

Buy

Apr 20, 2026

Target

$185.00

Current

$70.65

Performance

-29.60%

NKTR was rated Buy by Arthur He on Apr 20, 2026, with a price objective of 185. This case shows how bullish projections can fail, with the stock now below 70.65.

ADAG

Buy

Aug 15, 2025

Target

$7.00

Current

$3.31

Performance

95.86%

On Aug 15, 2025, Arthur He initiated coverage on ADAG with a Buy rating and target of 7. The stock’s climb of 95.86% since the call highlights the foresight in the rating.

LVTX

Hold

Aug 05, 2025

Target

$1.24

Current

$1.74

Performance

15.23%

Arthur He issued a Neutral recommendation for LVTX on Aug 05, 2025, price target set at 1.24. A neutral call gave way to stronger-than-expected performance, closing in on 1.24.

AUPH

Buy

Jul 30, 2025

Target

$17.00

Current

$16.11

Performance

78.01%

On Jul 30, 2025, AUPH was evaluated by Arthur He, who gave a Buy rating and target of 17. This case illustrates how a timely bullish rating can translate into tangible gains of 78.01%.

ADAP

Hold

Jul 29, 2025

Target

—

Current

$0.05

Performance

-53.77%

Arthur He rated ADAP as Neutral on Jul 29, 2025, setting a price target of null. The cautious Hold call aligned with subsequent weakness, as shares slipped 53.77%.

BCAB

Hold

Mar 31, 2025

Target

—

Current

$1.74

Performance

-89.99%

On Mar 31, 2025, BCAB was given a Neutral rating by Arthur He, with a target price of null. The rating provided protection from downside risk as the stock fell to 1.735.

HOOK

Hold

Jan 10, 2025

Target

—

Current

$1.15

Performance

-46.51%

HOOK received a Neutral rating from Arthur He on Jan 10, 2025, aiming for null. The Hold stance proved prudent, with the market softening by 46.51%.

PSTX

Hold

Nov 26, 2024

Target

$9.00

Current

$9.50

Performance

1.28%

On Nov 26, 2024, Arthur He published a Neutral outlook on PSTX, with a target of 9. Sideways action left the Hold view intact, with no major move since 9.5.

Frequency Asked Questions

Who is Arthur He?

Arthur He is an analyst from HC Wainwright & Co. specializing in the Healthcare sector.

What is Arthur He's success rate?

Arthur He currently has a success rate of +50.21%.

How many ratings has Arthur He issued?

Arthur He has issued 17 stock ratings so far.

What is the average return of Arthur He's calls?

Their stock ratings have generated an average return of +18.78%.

What is Arthur He's ranking?

Arthur He is ranked #2483 out of 4771 analysts.

What types of ratings does Arthur He give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Arthur He?

You can follow Arthur He by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Arthur He?

Their latest rating was a Buy on IMA issued on 2026-08-21.